These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 10770453

  • 1. Nefazodone treatment for chronic posttraumatic stress disorder: an open trial.
    Davis LL, Nugent AL, Murray J, Kramer GL, Petty F.
    J Clin Psychopharmacol; 2000 Apr; 20(2):159-64. PubMed ID: 10770453
    [Abstract] [Full Text] [Related]

  • 2. Open trial of nefazodone for combat veterans with posttraumatic stress disorder.
    Garfield DA, Fichtner CG, Leveroni C, Mahableshwarkar A.
    J Trauma Stress; 2001 Jul; 14(3):453-60. PubMed ID: 11534877
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nefazodone in patients with treatment-refractory posttraumatic stress disorder.
    Zisook S, Chentsova-Dutton YE, Smith-Vaniz A, Kline NA, Ellenor GL, Kodsi AB, Gillin JC.
    J Clin Psychiatry; 2000 Mar; 61(3):203-8. PubMed ID: 10817106
    [Abstract] [Full Text] [Related]

  • 5. Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder.
    Hertzberg MA, Feldman ME, Beckham JC, Moore SD, Davidson JR.
    Ann Clin Psychiatry; 2002 Dec; 14(4):215-21. PubMed ID: 12630657
    [Abstract] [Full Text] [Related]

  • 6. Open trial of nefazodone for combat-related posttraumatic stress disorder.
    Hertzberg MA, Feldman ME, Beckham JC, Moore SD, Davidson JR.
    J Clin Psychiatry; 1998 Sep; 59(9):460-4. PubMed ID: 9771816
    [Abstract] [Full Text] [Related]

  • 7. Treatment of posttraumatic stress disorder with nefazodone.
    Davidson JR, Weisler RH, Malik ML, Connor KM.
    Int Clin Psychopharmacol; 1998 May; 13(3):111-3. PubMed ID: 9690977
    [Abstract] [Full Text] [Related]

  • 8. An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder.
    Gillin JC, Smith-Vaniz A, Schnierow B, Rapaport MH, Kelsoe J, Raimo E, Marler MR, Goyette LM, Stein MB, Zisook S.
    J Clin Psychiatry; 2001 Oct; 62(10):789-96. PubMed ID: 11816868
    [Abstract] [Full Text] [Related]

  • 9. The effect of nefazodone on subjective and objective sleep quality in posttraumatic stress disorder.
    Neylan TC, Lenoci M, Maglione ML, Rosenlicht NZ, Leykin Y, Metzler TJ, Schoenfeld FB, Marmar CR.
    J Clin Psychiatry; 2003 Apr; 64(4):445-50. PubMed ID: 12716248
    [Abstract] [Full Text] [Related]

  • 10. Nefazodone in post-traumatic stress disorder: results from six open-label trials.
    Hidalgo R, Hertzberg MA, Mellman T, Petty F, Tucker P, Weisler R, Zisook S, Chen S, Churchill E, Davidson J.
    Int Clin Psychopharmacol; 1999 Mar; 14(2):61-8. PubMed ID: 10220119
    [Abstract] [Full Text] [Related]

  • 11. Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.
    Villarreal G, Calais LA, Cañive JM, Lundy SL, Pickard J, Toney G.
    Psychopharmacol Bull; 2007 Mar; 40(2):6-18. PubMed ID: 17514183
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.
    McRae AL, Brady KT, Mellman TA, Sonne SC, Killeen TK, Timmerman MA, Bayles-Dazet W.
    Depress Anxiety; 2004 Mar; 19(3):190-6. PubMed ID: 15129422
    [Abstract] [Full Text] [Related]

  • 15. [Three paradigms in the treatment of posttraumatic stress disorder].
    Martényi F.
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):11-21. PubMed ID: 16167463
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA.
    J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fluoxetine versus placebo in posttraumatic stress disorder.
    Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC.
    J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.